Life Science Investing Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Life Science Investing Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors
Life Science Investing Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
life science investing Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
life science investing Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
Apollo Files NI 43-101 Technical Report for the Calico Silver Project Updated Mineral Resource Estimate
